TGFB1 and neoplasm: Based on the observed immune-phenotype, we propose that Treg associated with Cluster 2 tumors are characterized by IL-10 and TGFB1 overexpression, possibly induced by mutant KRAS tumor cells [125,128] or by endothelial cells through angiopoietin 2 [123].